Virtus Investment Advisers’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$83.9K Sell
6,001
-3,128
-34% -$43.7K 0.03% 407
2025
Q1
$123K Buy
+9,129
New +$123K 0.03% 390